Heat Shock Protein 90 Inhibitors Repress Latent Membrane Protein 1 (LMP1) Expression and Proliferation of Epstein-Barr Virus-Positive Natural Killer Cell Lymphoma

被引：33

作者：

Murata, Takayuki ^{[1
]}

Iwata, Seiko ^{[2
]}

Siddiquey, Mohammed Nure Alam ^{[2
]}

Kanazawa, Tetsuhiro ^{[2
]}

Goshima, Fumi ^{[2
]}

Kawashima, Daisuke ^{[1
]}

Kimura, Hiroshi ^{[2
]}

Tsurumi, Tatsuya ^{[1
]}

机构：

[1] Aichi Canc Ctr, Res Inst, Div Virol, Nagoya, Aichi 464, Japan

[2] Nagoya Univ, Dept Virol, Grad Sch Med, Nagoya, Aichi 4648601, Japan

来源：

PLOS ONE | 2013年 / 8卷 / 05期

关键词：

SIGNAL BINDING-PROTEIN; J-KAPPA; GENE-EXPRESSION; TRANSCRIPTION FACTORS; HSP90; INHIBITORS; HODGKIN LYMPHOMA; DOWN-REGULATION; NK CELLS; B-CELLS; LINES;

D O I：

10.1371/journal.pone.0063566

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Epstein-Barr virus (EBV) LMP1 is a major oncoprotein expressed in latent infection. It functions as a TNFR family member and constitutively activates cellular signals, such as NFkB, MAPK, JAK/STAT and AKT. We here screened small molecule inhibitors and isolated HSP90 inhibitors, Radicicol and 17-AAG, as candidates that suppress LMP1 expression and cell proliferation not only in EBV-positive SNK6 Natural Killer (NK) cell lymphoma cells, but also in B and T cells. Tumor formation in immunodefficient NOD/Shi-scid/IL-2R gamma(null) (NOG) mice was also retarded. These results suggest that HSP90 inhibitors can be alternative treatments for patients with EBV-positive malignancies.

引用

页数：6

共 50 条

[1] Regulation of the Fas pathway by LMP1 (latent membrane protein 1) of the Epstein-Barr virus (EBV)
Leroy, I
Faumont, N.
Meggetto, F.
Delsol, G.
Despeaux, M.
Laurent, G.
Quillet-Mary, A.
BULLETIN DU CANCER, 2007, 94 : S289 - S290
[2] Triptolide inhibits proliferation of Epstein-Barr virus-positive B lymphocytes by down-regulating expression of a viral protein LMP1
Zhou, Heng
Guo, Wei
Long, Cong
Wang, Huan
Wang, Jingchao
Sun, Xiaoping
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 456 (03) : 815 - 820
[3] The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex
Fries, KL
Miller, WE
Raab-Traub, N
VIROLOGY, 1999, 264 (01) : 159 - 166
[4] Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells
Li, HM
Zhuang, ZH
Wang, Q
Pang, JCS
Wang, XH
Wong, HL
Feng, HC
Jin, DY
Ling, MT
Wong, YC
Eliopoulos, AG
Young, LS
Huang, DP
Tsao, SW
ONCOGENE, 2004, 23 (25) : 4488 - 4494
[5] Regulation of Host microRNA Expression by Natural Variants of Epstein Barr Virus (EBV) Latent Membrane Protein 1 (LMP1).
Hatton, O.
Harris-Arnold, A.
Hui, A.
Maloney, E.
Krams, S. M.
Martinez, O. M.
AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 337 - 337
[6] Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease
Meij, P
Vervoort, MBHJ
Bloemena, E
Schouten, TE
Schwartz, C
Grufferman, S
Ambinder, RF
Middeldorp, JM
JOURNAL OF MEDICAL VIROLOGY, 2002, 68 (03) : 370 - 377
[7] Effects of Epstein-Barr virus latent membrane protein 1 (LMP1) on cell invasiveness and expression of endogenous microRNAs in human cells in vitro
Mueller-Coan, Barbara Grasiele
Cesarman, Ethel
De Oliveira, Deilson Elgui
CANCER RESEARCH, 2017, 77
[8] Epstein-Barr virus latent membrane protein 1 (LMP-1) in Hodgkin lymphoma patients in Morocco
Jabri, L.
Belbachir, A.
Karkouri, M.
Quachouch, M.
Quessar, A.
Madani, A.
Zamiati, S.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 44 - 44
[9] A Systematic Review of Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) Gene Variants in Nasopharyngeal Carcinoma
Banko, Ana
Miljanovic, Danijela
Lazarevic, Ivana
Cirkovic, Andja
PATHOGENS, 2021, 10 (08):
[10] Epstein-Barr virus latent membrane protein 1 (LMP1) regulates the aldehyde dehydrogenase (ALDH) positive cell population in nasopharyngeal carcinoma cell lines
Wu, J.
Su, H.
Li, G.
Huang, Y.
ACTA VIROLOGICA, 2019, 63 (03) : 322 - 327

← 1 2 3 4 5 →